tadalafil has been researched along with Peripheral Nerve Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hountras, P; Lane, T | 1 |
Hayashi, M; Imai, S; Kitada, N; Koyanagi, M; Matsubara, K; Nakagawa, S; Nakagawa, T; Ogihara, T; Omura, T; Yonezawa, A | 1 |
Chopp, M; Jia, L; Lu, M; Lu, X; Szalad, A; Wang, L; Zhang, RL; Zhang, ZG | 1 |
3 other study(ies) available for tadalafil and Peripheral Nerve Diseases
Article | Year |
---|---|
A 65-Year-Old Man With Weight Loss, Peripheral Neuropathy, and Lower Extremity Swelling.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Edema; Exercise Tolerance; Humans; Hypertension, Pulmonary; Lenalidomide; Male; Neoplasms, Plasma Cell; Peripheral Nervous System Diseases; Phosphodiesterase 5 Inhibitors; POEMS Syndrome; Positron Emission Tomography Computed Tomography; Stem Cell Transplantation; Syncope; Tadalafil; Weight Loss | 2022 |
Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in mice.
Topics: Animals; Behavior, Animal; Cryopyrin-Associated Periodic Syndromes; Ganglia, Spinal; Humans; Mice; Mice, Inbred C57BL; Oxaliplatin; Peripheral Nervous System Diseases; Phosphodiesterase 5 Inhibitors; Sciatic Nerve; Skin; Tadalafil; Vascular System Injuries; Vasodilator Agents | 2019 |
Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Gene Expression Regulation; Humans; Lymphokines; Mice; Mice, Inbred NOD; Motor Activity; Nerve Fibers; Nerve Growth Factor; Peripheral Nervous System Diseases; Platelet-Derived Growth Factor; Sciatic Nerve; Tadalafil | 2016 |